ES2154018T3 - Soluciones inyectables por via parenteral que contienen piroxicam. - Google Patents

Soluciones inyectables por via parenteral que contienen piroxicam.

Info

Publication number
ES2154018T3
ES2154018T3 ES97830103T ES97830103T ES2154018T3 ES 2154018 T3 ES2154018 T3 ES 2154018T3 ES 97830103 T ES97830103 T ES 97830103T ES 97830103 T ES97830103 T ES 97830103T ES 2154018 T3 ES2154018 T3 ES 2154018T3
Authority
ES
Spain
Prior art keywords
parenteral routes
injectable solutions
containing piroxicam
routes containing
piroxicam
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97830103T
Other languages
English (en)
Inventor
Evaristo Bertone
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PULITZER ITALIANA
Original Assignee
PULITZER ITALIANA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PULITZER ITALIANA filed Critical PULITZER ITALIANA
Application granted granted Critical
Publication of ES2154018T3 publication Critical patent/ES2154018T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Abstract

SOLUCIONES DE PIROXICAM INYECTABLES POR VIA PARENTERAL QUE TIENEN LA SIGUIENTE COMPOSICION: Y QUE OPCIONALMENTE CONTIENEN UN AGENTE BACTERIOSTATICO Y/O UN AGENTE ANESTESICO LOCAL.
ES97830103T 1996-03-15 1997-03-07 Soluciones inyectables por via parenteral que contienen piroxicam. Expired - Lifetime ES2154018T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96MI000501A IT1283252B1 (it) 1996-03-15 1996-03-15 Soluzioni di piroxicam iniettabili per via parenterale

Publications (1)

Publication Number Publication Date
ES2154018T3 true ES2154018T3 (es) 2001-03-16

Family

ID=11373628

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97830103T Expired - Lifetime ES2154018T3 (es) 1996-03-15 1997-03-07 Soluciones inyectables por via parenteral que contienen piroxicam.

Country Status (4)

Country Link
EP (1) EP0795329B1 (es)
DE (1) DE69703994T2 (es)
ES (1) ES2154018T3 (es)
IT (1) IT1283252B1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
AU2003100262B4 (en) * 2003-04-07 2003-09-18 Jurox Pty Ltd Stable carprofen composition
CN101217939A (zh) * 2005-05-27 2008-07-09 灵药生物技术有限公司 可注射组合物及制备这类组合物的方法
KR101383941B1 (ko) 2012-03-09 2014-04-10 동아에스티 주식회사 피록시캄 또는 약제학적으로 허용되는 그의 염과 히알루론산 또는 약제학적으로 허용되는 그의 염의 안정한 액상 조성물 및 그 제조방법
US10980886B2 (en) 2014-04-21 2021-04-20 Heron Therapeutics, Inc. Compositions of a polyorthoester and an organic acid excipient
US9801945B2 (en) 2014-04-21 2017-10-31 Heron Therapeutics, Inc. Long-acting polymeric delivery systems
WO2018048460A1 (en) 2014-04-21 2018-03-15 Heron Therapeutics, Inc. A pharmaceutical composition comprising a delivery system, an amide-type local anesthetic, and meloxicam
EP3134068B1 (en) 2014-04-21 2021-07-21 Heron Therapeutics, Inc. Long-acting polymeric delivery systems
WO2021146215A1 (en) 2020-01-13 2021-07-22 Durect Corporation Sustained release drug delivery systems with reduced impurities and related methods

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4434164A (en) * 1981-06-01 1984-02-28 Pfizer Inc. Crystalline benzothiazine dioxide salts
US4434163A (en) * 1981-06-01 1984-02-28 Pfizer Inc. Water-soluble benzothiazine dioxide salts
DE3217315C2 (de) * 1982-05-08 1986-05-22 Gödecke AG, 1000 Berlin Arzneimittelzubereitungen mit einem Gehalt an Oxicam-Derivaten
DE3437232A1 (de) * 1984-10-10 1986-04-17 Mack Chem Pharm Stabilisierte injektionsloesungen von piroxicam
IT1207994B (it) * 1986-01-03 1989-06-01 Therapicon Srl Sali idrosulubili di composti adattivita' antiinfiammatoria ed analgesica, loro preparazione ed utilizzo in composizioni farmaceutiche.
IT1216686B (it) * 1988-04-01 1990-03-08 Chiesi Farma Spa Formulazioni farmaceutiche acquose di piroxicam e procedimento per laloro preparazione.
JPH0418022A (ja) * 1990-05-10 1992-01-22 Fujikawa Kk ピロキシカムの安定水溶液ならびにその製造法
KR930010398B1 (ko) * 1990-09-05 1993-10-23 배명진 음성신호 파형에서 비대칭율을 이용한 전이구간 검출방법
US5420124A (en) * 1994-01-12 1995-05-30 Kim; Young S. Stable, painless piroxicam potassium injectable composition

Also Published As

Publication number Publication date
EP0795329A1 (en) 1997-09-17
DE69703994D1 (de) 2001-03-08
EP0795329B1 (en) 2001-01-31
DE69703994T2 (de) 2001-05-23
ITMI960501A0 (es) 1996-03-15
ITMI960501A1 (it) 1997-09-15
IT1283252B1 (it) 1998-04-16

Similar Documents

Publication Publication Date Title
DZ1763A1 (fr) Composition vaccinantes.
DE69607178T2 (de) Mikroemulsionsförmige Desinfektionszusammensetzung
ATE162945T1 (de) Mittel zur transdermalen applikation enthaltend 3-keto-desogestrel
DE69110785T2 (de) Narkosemittelverdampfer.
BR9611184B8 (pt) Composto e composição.
GB0123381D0 (en) Factor
DE69105462D1 (de) Desinfizierende Zusammensetzung.
DE69203695D1 (de) Sauerstoff aufnehmende Zusammensetzung.
NO911861D0 (no) Stabilisert fgf-sammensetning.
DE69300694D1 (de) Desinfizierende Zusammensetzungen.
BR9402890A (pt) Composição de lubrificante baseado em siloxano no segregador de hidrogênio.
DE69328681D1 (de) Selbstschmierende polybenzimidazole enthaltende zusammensetzung
MX9100710A (es) Agentes fitoprotectores que contienen isoxazolinas o isotiazolinas asi como nuevas isoxazolinas e isotiazolinas
ES2154018T3 (es) Soluciones inyectables por via parenteral que contienen piroxicam.
TR199802351T2 (xx) Topikal kullanım için bir veya birden fazla lokal anestezik ve anti-vajinit maddeler ihtiva eden anti-vajinit bileşimi.
DE69929544D1 (de) Attenuierte Pestiviren
FR2695297B1 (fr) Composition d'agent désinfectant.
DE69925475D1 (de) C11 oxymyl- und hydroxylamino-prostaglandine verwendbar als fp-agonisten
DE69112806D1 (de) Riechstoff.
MX9201825A (es) Composicion farmaceutica que contiene calcitonina.
FR2693738B1 (fr) Composition désinfectante et détergente.
MX9205556A (es) Mejoras en composiciones novedosas que comprenden pentafluoroetano y monoclorodifluorometano.
FR2663849B1 (fr) Composition cicatrisante a usage local.
ES2196802T3 (es) Lactatos de citronelilo y/o de dihidrocitronelilo, su preparacion y su utilizacion.
DE29614078U1 (de) Nasenpflaster mit Werbeaufdruck o.dgl.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 795329

Country of ref document: ES